This site is intended for health professionals only
Levemir® receives positive CHMP opinion for extended use in children as young as one year old
Related articles
New study supports earlier intervention in DMO
There are an estimated 497,100 children living with type I diabetes globally and incidence is increasing in many countries. (1) Young children with type I diabetes can be difficult to treat as their needs are in constant flux during growth and development, (2) with children aged six and under at greatest risk of severe hypoglycaemia and acute diabetes complications. (3)